Zurück
Ich hätte ja das SL nachgezogen, aber die Spielregeln erlauben das ja nicht. Also bis Freitag ist Daumendrücken angesagt.
audio.dogsonacid.com/dance.gif" style="max-width:560px" >
mitglied.lycos.de/ArbeiterX/Dr1.jpg" style="max-width:560px" >
Anzeige
Meldung des Tages: DiagnosTear Technologies: Zwei Durchstarter für 2026?!
Valence Technology - sofort einsteigen.
Beiträge:
42
Zugriffe: 8.123 / Heute: 4
Zugriffe: 8.123 / Heute: 4
|
| ||||||||||||||
Werbung
Entdecke die beliebtesten ETFs von Amundi
Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi IBEX 35 Doble Apalancado Diario (2x) UCITS ETF Acc
Perf. 12M: +128,02%
Amundi MSCI Greece UCITS ETF Dist
Perf. 12M: +56,48%
Amundi IBEX 35 UCITS ETF Dist
Perf. 12M: +55,79%
Amundi IBEX 35 UCITS ETF Acc
Perf. 12M: +55,76%
Ist doch auch was. Gehe schlafen.
Gruss E.
Gruss E.
Da gabs ja einige News in letzter Zeit - sieht nach wie vor gut aus.
Doc, und, what have you done?
Gruss E.
Gruss E.
Das hat dann wohl zum Ausbruch beigetragen. Ich übrigens bin seit Anfang der Woche zu 2,5$ dabei, wie auch bei DOCC - danke für den Tip!
Schon über eine Million Shares gehandelt - das Fünffache des normalen Umsatzes. Übrigens 7,7% des Freefloat ist short(3,3 Mio Shares).
Geteilte Freude ist doppelte Freude. Ich hatte vermutet, dass Du VLNC privat seit 1,70 hast, weil Du Sie im Depotwettbewerb für 1,70 reingelegt hattest.
Wir werden auch noch bei TEN die 4 Dollar sehen, I`m sure. Da kannste den Chart von FTUS drüberlegen, eineiige Zwillinge. Ich bin neben DOCC und OPSW bei SNCI (nicht SNIC) gut im Plus, gekauft für 2,35 ohne zu posten, bei SANG bin ich vor einer Woche eingestiegen, bei SLXP bin ich 60% vorne, bei UBET gut im Rennen, MSN hab ich noch, heute HGR eingekauft, vorgestern MDR für eine Woche, nix langfristiges, hatte ich geschrieben.
Mein bester 2 Tageszock war WFHC diese Woche, gekauft für 0,63 und weg für 0,97.
APWR hab ich heute mit Verlust verkauft, hatte ne kleine Zockposition für 3,05, die aktuellen Rechtsstreitigkeiten machen aber einen Anstieg wohl unmöglich. Bernd aus Kulmbach hatte Astropower in sein langfristiges Musterdepot neben Siemens gelegt vor ca. 3 Jahren, beide zu Kursen um 160, deswegen hab ich APWR nie aus den Augen verloren und nen Zock bei 3 Dollar erhofft.
Egal, und tschüss, weg mit Dreck.
Und, und.. völliges Neuland für mich, einen Call auf JNPR. Wenn JNPR über 12 geht, sollte der Call mindestens 100% gemacht haben.
Wärend der Blasenzeit vor 3 Jahren hatte ich JNPR für 180 Dollar gekauft, das waren noch Zeiten.
Ist doch Network-Time, wie siehst Du es langfristig? SONS spitze, Foundry spitze, JNPR bitte über 12 Dollar in 6 Wochen, der Chart gibt es mit den aktuellen Zahlen her, dann hab ich fett Kohle mit dem Call gescheffelt.
Die RSTN Aktie kauf ich wieder unter 1,30, falls es welche gibt, immer für nen 3 Tageszock gut.
Komischerweise finde ich meinen TALK America Thread nicht wieder, ich wollte ihn noch mal aufwärmen, denn ich hab als Erster über TALK in Deutschland geschrieben, da bin ich mir ziemlich sicher.
Liest Du Dir den Kram von dem Neuen Quadsan durch? Is ja mal nen neuer lustiger Vogel ins Board geflattert. CTCH hab ich mir in die WL gesetzt.
So, jetz muss ich schlafen, und zeig was Du kannst, bin auf Dein 3 Wochen Depot gespannt. Die Auswertung der letzten Runde gibst erst Sonntag, heute hab ich keine Zeit mehr, der Samstag ist voll verplant.
Gruss E.
Wir werden auch noch bei TEN die 4 Dollar sehen, I`m sure. Da kannste den Chart von FTUS drüberlegen, eineiige Zwillinge. Ich bin neben DOCC und OPSW bei SNCI (nicht SNIC) gut im Plus, gekauft für 2,35 ohne zu posten, bei SANG bin ich vor einer Woche eingestiegen, bei SLXP bin ich 60% vorne, bei UBET gut im Rennen, MSN hab ich noch, heute HGR eingekauft, vorgestern MDR für eine Woche, nix langfristiges, hatte ich geschrieben.
Mein bester 2 Tageszock war WFHC diese Woche, gekauft für 0,63 und weg für 0,97.
APWR hab ich heute mit Verlust verkauft, hatte ne kleine Zockposition für 3,05, die aktuellen Rechtsstreitigkeiten machen aber einen Anstieg wohl unmöglich. Bernd aus Kulmbach hatte Astropower in sein langfristiges Musterdepot neben Siemens gelegt vor ca. 3 Jahren, beide zu Kursen um 160, deswegen hab ich APWR nie aus den Augen verloren und nen Zock bei 3 Dollar erhofft.
Egal, und tschüss, weg mit Dreck.
Und, und.. völliges Neuland für mich, einen Call auf JNPR. Wenn JNPR über 12 geht, sollte der Call mindestens 100% gemacht haben.
Wärend der Blasenzeit vor 3 Jahren hatte ich JNPR für 180 Dollar gekauft, das waren noch Zeiten.
Ist doch Network-Time, wie siehst Du es langfristig? SONS spitze, Foundry spitze, JNPR bitte über 12 Dollar in 6 Wochen, der Chart gibt es mit den aktuellen Zahlen her, dann hab ich fett Kohle mit dem Call gescheffelt.
Die RSTN Aktie kauf ich wieder unter 1,30, falls es welche gibt, immer für nen 3 Tageszock gut.
Komischerweise finde ich meinen TALK America Thread nicht wieder, ich wollte ihn noch mal aufwärmen, denn ich hab als Erster über TALK in Deutschland geschrieben, da bin ich mir ziemlich sicher.
Liest Du Dir den Kram von dem Neuen Quadsan durch? Is ja mal nen neuer lustiger Vogel ins Board geflattert. CTCH hab ich mir in die WL gesetzt.
So, jetz muss ich schlafen, und zeig was Du kannst, bin auf Dein 3 Wochen Depot gespannt. Die Auswertung der letzten Runde gibst erst Sonntag, heute hab ich keine Zeit mehr, der Samstag ist voll verplant.
Gruss E.
Ich hatte ja geschrieben, dass ich das Depot fast komplett geräumt hatte, da ich nicht mit einem schnellen Kriegsende rechnete.
So sind auch TEN und MSN rausgeflogen...
Ansonsten war gestern der beste Tag seit langem. Außer DIGE alles schön im grünen Bereich, z.T. zweistellig. Aber Gewinne sinds ja erst, wenn verkauft ist.
Es ist weiter Stockpicking angesagt. Kein Wunder bei dem Cash der an der Seitenlinie liegt. Auch die Vermögensverwalter/Fondmanager halten nach Werten Ausschau, die bessere Zahlen präsentieren, gute Perspektiven oder schlicht gute Reboundchancen haben.
Mal sehen, ob das Schema auch weiterhin funktioniert, wenn wir langsam in die traditionell schwächeren Monate kommen.
Da die Shortquote aber allgemein immer noch sehr hoch sein dürfte, werden wir wohl immer wieder einen "Homerun" erleben, sobald eine Firma positiv überrascht.
So sind auch TEN und MSN rausgeflogen...
Ansonsten war gestern der beste Tag seit langem. Außer DIGE alles schön im grünen Bereich, z.T. zweistellig. Aber Gewinne sinds ja erst, wenn verkauft ist.
Es ist weiter Stockpicking angesagt. Kein Wunder bei dem Cash der an der Seitenlinie liegt. Auch die Vermögensverwalter/Fondmanager halten nach Werten Ausschau, die bessere Zahlen präsentieren, gute Perspektiven oder schlicht gute Reboundchancen haben.
Mal sehen, ob das Schema auch weiterhin funktioniert, wenn wir langsam in die traditionell schwächeren Monate kommen.
Da die Shortquote aber allgemein immer noch sehr hoch sein dürfte, werden wir wohl immer wieder einen "Homerun" erleben, sobald eine Firma positiv überrascht.
MDR hatte ich am 10.04. für 2,60 gekauft, hatte ich Dir geschrieben. Sollte nix langfristiges sein, nach einer Woche mit mageren 20% abgegeben, jetzt wären es weit über 100%.
WFHC taucht auch auf am 12.04. auf, meine alte neue Position.
Jetzt hat Grueni MDR ins Spieldepot genommen.
Gruss E.
Kurshistorie NYSE MDR:
Datum Erster Hoch Tief Letzter Umsatz
09.05.2003 4,73 5,17 4,73 5,08 1.250.900
08.05.2003 4,90 5,00 4,25 4,73 1.448.200
07.05.2003 3,99 4,96 3,69 4,93 3.439.100
06.05.2003 3,29 3,32 3,13 3,23 574.000
05.05.2003 3,35 3,47 3,23 3,26 560.900
02.05.2003 3,25 3,39 3,22 3,35 1.144.100
01.05.2003 3,25 3,27 3,18 3,25 367.500
30.04.2003 3,11 3,26 3,10 3,25 362.400
29.04.2003 3,10 3,30 3,09 3,19 382.300
28.04.2003 3,25 3,30 3,18 3,24 636.000
25.04.2003 3,42 3,48 3,20 3,25 285.900
24.04.2003 3,20 3,50 3,12 3,40 1.285.500
23.04.2003 2,90 3,08 2,88 3,05 242.000
22.04.2003 2,84 2,99 2,80 2,93 276.900
21.04.2003 2,82 2,91 2,80 2,86 207.600
18.04.2003 2,81 2,94 2,75 2,91 328.800
17.04.2003 2,81 2,94 2,75 2,91 328.800
16.04.2003 2,70 2,85 2,70 2,81 532.700
15.04.2003 2,70 2,72 2,66 2,72 398.200
chart.bigcharts.com/bc3/quickchart/...99&mocktick=1&rand=6867"
WFHC taucht auch auf am 12.04. auf, meine alte neue Position.
Jetzt hat Grueni MDR ins Spieldepot genommen.
Gruss E.
Kurshistorie NYSE MDR:
Datum Erster Hoch Tief Letzter Umsatz
09.05.2003 4,73 5,17 4,73 5,08 1.250.900
08.05.2003 4,90 5,00 4,25 4,73 1.448.200
07.05.2003 3,99 4,96 3,69 4,93 3.439.100
06.05.2003 3,29 3,32 3,13 3,23 574.000
05.05.2003 3,35 3,47 3,23 3,26 560.900
02.05.2003 3,25 3,39 3,22 3,35 1.144.100
01.05.2003 3,25 3,27 3,18 3,25 367.500
30.04.2003 3,11 3,26 3,10 3,25 362.400
29.04.2003 3,10 3,30 3,09 3,19 382.300
28.04.2003 3,25 3,30 3,18 3,24 636.000
25.04.2003 3,42 3,48 3,20 3,25 285.900
24.04.2003 3,20 3,50 3,12 3,40 1.285.500
23.04.2003 2,90 3,08 2,88 3,05 242.000
22.04.2003 2,84 2,99 2,80 2,93 276.900
21.04.2003 2,82 2,91 2,80 2,86 207.600
18.04.2003 2,81 2,94 2,75 2,91 328.800
17.04.2003 2,81 2,94 2,75 2,91 328.800
16.04.2003 2,70 2,85 2,70 2,81 532.700
15.04.2003 2,70 2,72 2,66 2,72 398.200
Als kleine Erinnerung.
Gruss E.
Gruss E.
ULBI ist auch erwähnenswert.
Gruss E.
chart.bigcharts.com/bc3/quickchart/...43&mocktick=1&rand=6050"
Ultralife Batteries, Inc. Announces Multi-Million Dollar Private Label Deal; Company's 9-Volt Lithium Batteries To Be Marketed Under Major Brand
MONDAY, MAY 19, 2003 8:41 AM
- BusinessWire
NEWARK, N.Y., May 19, 2003 (BUSINESS WIRE) -- Ultralife Batteries, Inc. (ULBI) today announced the receipt of a multi-million dollar order from a major consumer products company for a private-labeled version of its popular 9-volt lithium battery.
Production will begin this month for scheduled shipments starting in June and extending throughout 2003.
John D. Kavazanjian, Ultralife's president and chief executive officer, said, "This order, from a well-recognized consumer-brand company, represents a significant accomplishment in our efforts to open new channels of distribution for our products worldwide and will contribute to our $65 million revenue goal for the year. We are extremely pleased and honored to have our battery represented by a company known throughout the world for the high quality, performance and brand recognition of its products."
Joseph N. Barrella, Ultralife's senior vice president of technology and new business development, said, "The formation of this new business relationship is a major achievement in the growth of our 9-volt product line. We look forward to this relationship resulting in expansion in existing and new markets for this and other products."
Ultralife's 9-volt lithium battery is a consumer-replaceable battery that lasts up to five times longer than alkaline 9-volt batteries and up to 10 times longer than carbon-zinc batteries. This primary (non-rechargeable) battery has the highest energy density, flattest discharge voltage, longest shelf life, widest operating temperature range, and lightest weight of any comparable-sized 9-volt battery. The battery provides the longest life in commercial and consumer applications including medical, wireless security, safety, music, and industrial products.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of customized and standard lithium primary, lithium ion and lithium polymer rechargeable batteries. Ultralife manufactures high-energy batteries utilizing advanced lithium technology. Our Primary (non-rechargeable), lithium ion and lithium polymer rechargeable batteries are used in military, industrial and consumer portable electronic products. OEM and retail customers include Energizer, Kidde Safety, Philips Medical Systems, Radio Shack, and the national defense agencies of the United States, United Kingdom and Germany.
This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: worsening global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.
Detailed information on Ultralife is available at the Company's web site, www.ultralifebatteries.com.
Ultralife(R) is a registered trademark of Ultralife Batteries, Inc.
SOURCE: Ultralife Batteries, Inc.
Ultralife Batteries, Inc.
Julius Cirin, 315/332-7100
jcirin@ulbi.com
or
Lippert/Heilshorn & Associates, Inc.
Investor Relations Contact:
Jody Burfening, 212/838-3777
jks@lhai.com
or
Lippert/Heilshorn & Associates, Inc.
Media Contact:
Chenoa Taitt, 212/201-6635
ctaitt@lhai.com
www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.
Gruss E.
Ultralife Batteries, Inc. Announces Multi-Million Dollar Private Label Deal; Company's 9-Volt Lithium Batteries To Be Marketed Under Major Brand
MONDAY, MAY 19, 2003 8:41 AM
- BusinessWire
NEWARK, N.Y., May 19, 2003 (BUSINESS WIRE) -- Ultralife Batteries, Inc. (ULBI) today announced the receipt of a multi-million dollar order from a major consumer products company for a private-labeled version of its popular 9-volt lithium battery.
Production will begin this month for scheduled shipments starting in June and extending throughout 2003.
John D. Kavazanjian, Ultralife's president and chief executive officer, said, "This order, from a well-recognized consumer-brand company, represents a significant accomplishment in our efforts to open new channels of distribution for our products worldwide and will contribute to our $65 million revenue goal for the year. We are extremely pleased and honored to have our battery represented by a company known throughout the world for the high quality, performance and brand recognition of its products."
Joseph N. Barrella, Ultralife's senior vice president of technology and new business development, said, "The formation of this new business relationship is a major achievement in the growth of our 9-volt product line. We look forward to this relationship resulting in expansion in existing and new markets for this and other products."
Ultralife's 9-volt lithium battery is a consumer-replaceable battery that lasts up to five times longer than alkaline 9-volt batteries and up to 10 times longer than carbon-zinc batteries. This primary (non-rechargeable) battery has the highest energy density, flattest discharge voltage, longest shelf life, widest operating temperature range, and lightest weight of any comparable-sized 9-volt battery. The battery provides the longest life in commercial and consumer applications including medical, wireless security, safety, music, and industrial products.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of customized and standard lithium primary, lithium ion and lithium polymer rechargeable batteries. Ultralife manufactures high-energy batteries utilizing advanced lithium technology. Our Primary (non-rechargeable), lithium ion and lithium polymer rechargeable batteries are used in military, industrial and consumer portable electronic products. OEM and retail customers include Energizer, Kidde Safety, Philips Medical Systems, Radio Shack, and the national defense agencies of the United States, United Kingdom and Germany.
This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: worsening global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.
Detailed information on Ultralife is available at the Company's web site, www.ultralifebatteries.com.
Ultralife(R) is a registered trademark of Ultralife Batteries, Inc.
SOURCE: Ultralife Batteries, Inc.
Ultralife Batteries, Inc.
Julius Cirin, 315/332-7100
jcirin@ulbi.com
or
Lippert/Heilshorn & Associates, Inc.
Investor Relations Contact:
Jody Burfening, 212/838-3777
jks@lhai.com
or
Lippert/Heilshorn & Associates, Inc.
Media Contact:
Chenoa Taitt, 212/201-6635
ctaitt@lhai.com
www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.
Das darf gesagt werden.
Gruss E.
Gruss E.
die Zahlen von VLNC am 26.06.03 nicht wirklich prickelnd, erwarte wurde ein Verlust von 0,14, ist aber ein etwas höherer Verlust pro Share bei rumgekommen. Dann gehts runter, ist normal.
Für die Zukunft ist allerdings nicht auszuschliessen, dass Gewinne erwirtschaftet werden. Ja dann schreib ich hier weiter.
Gruss E.
Valence Reports Fourth Quarter and Year-End Results
THURSDAY, JUNE 26, 2003 10:01 AM
- BusinessWire
AUSTIN, Texas, Jun 26, 2003 (BUSINESS WIRE) -- Valence Technology, Inc. (VLNC) , a leader in the development and commercialization of Saphion(TM) technology and Lithium-ion polymer rechargeable batteries, today reported fourth quarter and year-end financial results for its fiscal year 2003 ended March 31, 2003.
For the fiscal year ended March 31, 2003, the Company reported revenue of $2.6 million, compared with $4.9 million in fiscal year 2002. The Company reported a net loss of $37.9 million, or $0.65 per basic and diluted share, an improvement over a net loss of $69.6 million, or $1.53 per basic and diluted share in fiscal year 2002.
"Fiscal 2003 has been marked by strong execution and significant accomplishments," stated Stephan Godevais, chairman and CEO of Valence. "Just over two years ago, we were solely a research and development company. Today, we are a company with a proven, new technology, relevant products and solid customer relationships. We have a tremendous opportunity ahead of us, and we look forward to pursuing it aggressively."
For the fourth quarter of fiscal 2003 revenue was $1.2 million, up from $638,000 in the third quarter of 2003, and up from $386,000 in the fourth quarter of fiscal year 2002. N-Charge(TM) sales represented 30 percent of total revenue and increased 38 percent over the third quarter. The Company reported a net loss of $10.1 million, or $0.13 per basic and diluted share, in the fourth quarter versus a net loss of $8.6 million, or $0.14 per basic and diluted share, in the third quarter of fiscal 2003, and a net loss of $8.2 million, or $0.18 per basic and diluted share, in the fourth quarter of fiscal 2002.
Für die Zukunft ist allerdings nicht auszuschliessen, dass Gewinne erwirtschaftet werden. Ja dann schreib ich hier weiter.
Gruss E.
Valence Reports Fourth Quarter and Year-End Results
THURSDAY, JUNE 26, 2003 10:01 AM
- BusinessWire
AUSTIN, Texas, Jun 26, 2003 (BUSINESS WIRE) -- Valence Technology, Inc. (VLNC) , a leader in the development and commercialization of Saphion(TM) technology and Lithium-ion polymer rechargeable batteries, today reported fourth quarter and year-end financial results for its fiscal year 2003 ended March 31, 2003.
For the fiscal year ended March 31, 2003, the Company reported revenue of $2.6 million, compared with $4.9 million in fiscal year 2002. The Company reported a net loss of $37.9 million, or $0.65 per basic and diluted share, an improvement over a net loss of $69.6 million, or $1.53 per basic and diluted share in fiscal year 2002.
"Fiscal 2003 has been marked by strong execution and significant accomplishments," stated Stephan Godevais, chairman and CEO of Valence. "Just over two years ago, we were solely a research and development company. Today, we are a company with a proven, new technology, relevant products and solid customer relationships. We have a tremendous opportunity ahead of us, and we look forward to pursuing it aggressively."
For the fourth quarter of fiscal 2003 revenue was $1.2 million, up from $638,000 in the third quarter of 2003, and up from $386,000 in the fourth quarter of fiscal year 2002. N-Charge(TM) sales represented 30 percent of total revenue and increased 38 percent over the third quarter. The Company reported a net loss of $10.1 million, or $0.13 per basic and diluted share, in the fourth quarter versus a net loss of $8.6 million, or $0.14 per basic and diluted share, in the third quarter of fiscal 2003, and a net loss of $8.2 million, or $0.18 per basic and diluted share, in the fourth quarter of fiscal 2002.
Die haben aus einem Verlust von 0,23 einen Gewinn von 0,02 gezaubert und wichtige Verträge mit der Army, kann ich fast selber nicht mehr lesen.
Die US-Streitkräfte sind ein wichtiger Partner für viele Unternehmen, da gibts verdammt viele.
Also, abwarten ob VLNC in die Gewinnzone kommt, dann dürfen wir über Kurse von 10 Dollar reden.
Gruss E.
Ultralife Batteries, Inc. Reports First Quarter EPS of $0.02 on Revenue of $15.4 Million; Revenues Increase 74% Over Prior Year; Operating Profit is $0.6 Million
TUESDAY, MAY 13, 2003 7:30 AM
- BusinessWire
NEWARK, N.Y., May 13, 2003 (BUSINESS WIRE) -- Ultralife Batteries, Inc. (ULBI) today is reporting operating income of $0.6 million and net income of $0.3 million, or $0.02 per share, on revenues of $15.4 million for the quarter ended March 29, 2003. These revenues represent a 74% increase over the Company's previous quarterly record of $8.9 million reported for the same three-month period a year ago. In addition, the Company's operating cash flow, defined as operating income plus depreciation and amortization, amounted to $1.3 million.
Revenue growth was fueled by greater demand for the Company's HiRate(R) battery products, particularly related to orders for UBI5390 batteries from the U.S. military used in a wide variety of communications and weapons applications. In addition, shipments of 9-volt batteries reached a quarterly record, and revenues from battery pack assemblies continued to increase.
Consolidated gross margin for the first quarter of 2003 was $3.2 million, an improvement of more than $2.2 million over the same quarter a year ago. Higher primary battery sales volumes, partially offset by ramp-up costs associated with the rapid growth in production levels, resulted in the gross margin increase.
The Company achieved operating income of $0.6 million compared to an operating loss of $2.1 million a year earlier. This progress resulted from the improvement in gross margins, as well as lower research and development costs attributable to the Company's rechargeable operations.
Net income for the quarter ended March 29, 2003 was $0.3 million, or $0.02 per share, compared to a net loss of $2.8 million, or $0.23 per share in the same three-month period last year
Die US-Streitkräfte sind ein wichtiger Partner für viele Unternehmen, da gibts verdammt viele.
Also, abwarten ob VLNC in die Gewinnzone kommt, dann dürfen wir über Kurse von 10 Dollar reden.
Gruss E.
Ultralife Batteries, Inc. Reports First Quarter EPS of $0.02 on Revenue of $15.4 Million; Revenues Increase 74% Over Prior Year; Operating Profit is $0.6 Million
TUESDAY, MAY 13, 2003 7:30 AM
- BusinessWire
NEWARK, N.Y., May 13, 2003 (BUSINESS WIRE) -- Ultralife Batteries, Inc. (ULBI) today is reporting operating income of $0.6 million and net income of $0.3 million, or $0.02 per share, on revenues of $15.4 million for the quarter ended March 29, 2003. These revenues represent a 74% increase over the Company's previous quarterly record of $8.9 million reported for the same three-month period a year ago. In addition, the Company's operating cash flow, defined as operating income plus depreciation and amortization, amounted to $1.3 million.
Revenue growth was fueled by greater demand for the Company's HiRate(R) battery products, particularly related to orders for UBI5390 batteries from the U.S. military used in a wide variety of communications and weapons applications. In addition, shipments of 9-volt batteries reached a quarterly record, and revenues from battery pack assemblies continued to increase.
Consolidated gross margin for the first quarter of 2003 was $3.2 million, an improvement of more than $2.2 million over the same quarter a year ago. Higher primary battery sales volumes, partially offset by ramp-up costs associated with the rapid growth in production levels, resulted in the gross margin increase.
The Company achieved operating income of $0.6 million compared to an operating loss of $2.1 million a year earlier. This progress resulted from the improvement in gross margins, as well as lower research and development costs attributable to the Company's rechargeable operations.
Net income for the quarter ended March 29, 2003 was $0.3 million, or $0.02 per share, compared to a net loss of $2.8 million, or $0.23 per share in the same three-month period last year
Tschüss für heute.
Gruss E.
chart.bigcharts.com/bc3/quickchart/...31&mocktick=1&rand=9839"
Ultralife Batteries, Inc. Receives $3.1 Million Contract from the US Military to Expand Battery Production Capability Additional Equipment Positions Ultralife to More Than Double BA-5390 Battery Manufacturing Capability
NEWARK, N.Y., Sep 24, 2003 (BUSINESS WIRE) -- Ultralife Batteries, Inc.
(NASDAQ: ULBI) has signed a contract with the U.S. Department of the Army -
Communications and Electronics Command (CECOM) whereby Ultralife will receive
$3.1 million to purchase on behalf of CECOM, manufacturing equipment to expand
the company's BA-5390 lithium-manganese dioxide battery manufacturing capability
at its Newark, New York factory. The company expects to complete the equipment
purchase and installation by February 2004.
After completing the equipment installation, Ultralife expects to have the
capability to produce revenue of more than $9 million per month of its BA-5390
batteries as new orders are received. This capability represents more than
double the company's BA-5390 manufacturing capability during the second quarter
of 2003.
"Ultralife is pursuing a diverse set of long-term growth opportunities, one of
which is to capitalize on the US military's conversion from lithium-sulfur
dioxide to lithium-manganese dioxide batteries," said John Kavazanjian,
Ultralife's president and chief executive officer. "The addition of this
equipment positions Ultralife for a new level of production readiness to meet
the military's growing demand for BA-5390 batteries."
Joseph N. Barrella, Ultralife's senior vice president of new business
development, added, "We are extremely pleased to support the military's
increasing demand for high-energy, long-lasting lithium-manganese dioxide
batteries. According to CECOM, the US military has an urgent need for Ultralife
to increase its production capability for our BA-5390 batteries. We believe this
equipment contract underscores the US military's recognition of the superior
performance and high quality of our batteries and strengthens our company's
position as the major supplier of this much needed battery."
The BA-5390 is a lithium-manganese dioxide primary (non-rechargeable) battery,
and with 50 percent more energy, is an alternative to the lithium-sulfur dioxide
BA-5590 battery, the most widely used military battery in the US Armed Forces.
The BA-5390 is widely used to power more than 50 military applications and
provides soldiers with the latest and best battery technology in a cost
effective manner.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of standard and
customized lithium primary (non-rechargeable), lithium ion and lithium polymer
rechargeable batteries. Ultralife's high-energy batteries use advanced lithium
technology and are used in military, industrial and consumer portable electronic
products. Through its range of standard products and ability to customize for a
wide range of applications, Ultralife is able to provide the next generation of
battery solutions. OEM, retail and government customers include Energizer, Kidde
Safety, Philips Medical Systems, Radio Shack and the national defense agencies
of the United States and United Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research facilities are in
Newark, New York, near Rochester. Ultralife (UK) Ltd., a second manufacturing
and research facility, is located in Abingdon, UK. Both facilities are
ISO-9001/2000 certified.
This press release may contain forward-looking statements based on current
expectations that involve a number of risks and uncertainties. The potential
risks and uncertainties that could cause actual results to differ materially
include: worsening global economic conditions, increased competitive environment
and pricing pressures, disruptions related to restructuring actions and delays.
Further information on these factors and other factors that could affect
Ultralife's financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form 10-K.
Detailed information on Ultralife is available at the Company's web site,
www.ultralifebatteries.com.
Ultralife(R) is a registered trademark Ultralife Batteries, Inc.
SOURCE: Ultralife Batteries, Inc.
Gruss E.
Ultralife Batteries, Inc. Receives $3.1 Million Contract from the US Military to Expand Battery Production Capability Additional Equipment Positions Ultralife to More Than Double BA-5390 Battery Manufacturing Capability
NEWARK, N.Y., Sep 24, 2003 (BUSINESS WIRE) -- Ultralife Batteries, Inc.
(NASDAQ: ULBI) has signed a contract with the U.S. Department of the Army -
Communications and Electronics Command (CECOM) whereby Ultralife will receive
$3.1 million to purchase on behalf of CECOM, manufacturing equipment to expand
the company's BA-5390 lithium-manganese dioxide battery manufacturing capability
at its Newark, New York factory. The company expects to complete the equipment
purchase and installation by February 2004.
After completing the equipment installation, Ultralife expects to have the
capability to produce revenue of more than $9 million per month of its BA-5390
batteries as new orders are received. This capability represents more than
double the company's BA-5390 manufacturing capability during the second quarter
of 2003.
"Ultralife is pursuing a diverse set of long-term growth opportunities, one of
which is to capitalize on the US military's conversion from lithium-sulfur
dioxide to lithium-manganese dioxide batteries," said John Kavazanjian,
Ultralife's president and chief executive officer. "The addition of this
equipment positions Ultralife for a new level of production readiness to meet
the military's growing demand for BA-5390 batteries."
Joseph N. Barrella, Ultralife's senior vice president of new business
development, added, "We are extremely pleased to support the military's
increasing demand for high-energy, long-lasting lithium-manganese dioxide
batteries. According to CECOM, the US military has an urgent need for Ultralife
to increase its production capability for our BA-5390 batteries. We believe this
equipment contract underscores the US military's recognition of the superior
performance and high quality of our batteries and strengthens our company's
position as the major supplier of this much needed battery."
The BA-5390 is a lithium-manganese dioxide primary (non-rechargeable) battery,
and with 50 percent more energy, is an alternative to the lithium-sulfur dioxide
BA-5590 battery, the most widely used military battery in the US Armed Forces.
The BA-5390 is widely used to power more than 50 military applications and
provides soldiers with the latest and best battery technology in a cost
effective manner.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of standard and
customized lithium primary (non-rechargeable), lithium ion and lithium polymer
rechargeable batteries. Ultralife's high-energy batteries use advanced lithium
technology and are used in military, industrial and consumer portable electronic
products. Through its range of standard products and ability to customize for a
wide range of applications, Ultralife is able to provide the next generation of
battery solutions. OEM, retail and government customers include Energizer, Kidde
Safety, Philips Medical Systems, Radio Shack and the national defense agencies
of the United States and United Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research facilities are in
Newark, New York, near Rochester. Ultralife (UK) Ltd., a second manufacturing
and research facility, is located in Abingdon, UK. Both facilities are
ISO-9001/2000 certified.
This press release may contain forward-looking statements based on current
expectations that involve a number of risks and uncertainties. The potential
risks and uncertainties that could cause actual results to differ materially
include: worsening global economic conditions, increased competitive environment
and pricing pressures, disruptions related to restructuring actions and delays.
Further information on these factors and other factors that could affect
Ultralife's financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form 10-K.
Detailed information on Ultralife is available at the Company's web site,
www.ultralifebatteries.com.
Ultralife(R) is a registered trademark Ultralife Batteries, Inc.
SOURCE: Ultralife Batteries, Inc.
Frühstück ist fertig, eigentlich keine Neuengagements geplant heute. Was ich hab, läuft auch ohne meine Anwesenheit.
Besser ich mache nichts heute, deshalb tschüss und einen erfolgreichen Tag.
Gruss E.
Besser ich mache nichts heute, deshalb tschüss und einen erfolgreichen Tag.
Gruss E.
Gruss E.
Tuesday, January 6, 2004 04:19 PM ET Printer-friendly version
NEW YORK -(Dow Jones)- Below is Thomson Financial's recap of the top 2003 buyers and sellers among corporate insiders:
Companies with the Highest Level of Insider Buying
Valence Technology Inc. (VLNC, news), a leading battery technology developer, topped the list of companies with the largest aggregate insider purchases in 2003. Director Carl Berg accounted for all $21.6 million of the firm's insider buying last year. Second and third on the list were Energizer Holdings (ENR, news) and Covista Communications (CVST, news) - with total acquisitions worth $18 million and $ 17 million, respectively. Rounding out the top five places were natural gas producer Chesapeake Energy Corp. (CHK, news) with $15 million in purchases and electronic game technology maker WMS Industries Inc. (WMS, news) at $14 million.
Tuesday, January 6, 2004 04:19 PM ET Printer-friendly version
NEW YORK -(Dow Jones)- Below is Thomson Financial's recap of the top 2003 buyers and sellers among corporate insiders:
Companies with the Highest Level of Insider Buying
Valence Technology Inc. (VLNC, news), a leading battery technology developer, topped the list of companies with the largest aggregate insider purchases in 2003. Director Carl Berg accounted for all $21.6 million of the firm's insider buying last year. Second and third on the list were Energizer Holdings (ENR, news) and Covista Communications (CVST, news) - with total acquisitions worth $18 million and $ 17 million, respectively. Rounding out the top five places were natural gas producer Chesapeake Energy Corp. (CHK, news) with $15 million in purchases and electronic game technology maker WMS Industries Inc. (WMS, news) at $14 million.
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem VALENCE TECHNOLOGY Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 9 | Valence- die-Aktie | knarf.iz | stier1981 | 05.02.14 07:57 | ||
| 7 Gute Gründe: 884481 | knarf.iz | 07.02.06 12:15 | ||||
| 41 | Valence Technology - sofort einsteigen. | Eskimato | Eskimato | 15.01.04 01:26 |